tirzepatide regulatory filings FDA says the weight-loss drug shortage is over FDA's Removal of Semaglutide and

Many people taking metformin for type 2 diabetes or prediabetes wonder whether adding a GLP-1 receptor agonist like Mounjaro (tirzepatide) is safe

How Much Does Lip Augmentation Cost in Washington, D.C

This ensures glycogen is available when you need it most

(2000): The potential role of fatty acids in attention-deficit/hyperactivity disorder

Those of us adhering strictly to recommendations not to initiate GLP-1 receptor agonists during the shortage over the last 6 months, to avoid jeopardising supplies to those already being treated, will already have identified people with type 2 diabetes who would benefit from the glucose-lowering and weight-reducing effects of tirzepatide

Clinical trials have demonstrated weight loss in people with type 2 diabetes, typically in the range of 5-12% at higher doses in the SURPASS clinical trials